1 - 25 of 54 results for author:"Futreal P.A." in Literature citations
Results Customize
› Repeat search in UniProtKB (565)
| Clinically significant copy number alterations and complex rearrangements of MYB and NFIB in head and neck adenoid cystic carcinoma. Persson M., Andren Y., Moskaluk C.A., Frierson H.F. Jr., Cooke S.L., Futreal P.A., Kling T., Nelander S., Nordkvist A., Persson F. et al. Genes Chromosomes Cancer 51:805-817(2012) · Mapped (27) |
| Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes. Zang Z.J., Cutcutache I., Poon S.L., Zhang S.L., McPherson J.R., Tao J., Rajasegaran V., Heng H.L., Deng N., Gan A. et al. Nat. Genet. 44:570-574(2012) · Mapped (3) |
| Genome sequencing and analysis of the Tasmanian devil and its transmissible cancer. Murchison E.P., Schulz-Trieglaff O.B., Ning Z., Alexandrov L.B., Bauer M.J., Fu B., Hims M., Ding Z., Ivakhno S., Stewart C. et al. Cell 148:780-791(2012) · UniProtKB (13) |
| Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms. Chronic Myeloid Disorders Working Group of the International Cancer Genome Consortium and of the Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative Blood 118:6239-6246(2011) · Mapped (9) |
| Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. Chronic Myeloid Disorders Working Group of the International Cancer Genome Consortium N. Engl. J. Med. 365:1384-1395(2011) · Mapped (9) |
| Novel chromosomal rearrangements and break points at the t(6;9) in salivary adenoid cystic carcinoma: association with MYB-NFIB chimeric fusion, MYB expression, and clinical outcome. Mitani Y., Rao P.H., Futreal P.A., Roberts D.B., Stephens P.J., Zhao Y.J., Zhang L., Mitani M., Weber R.S., Lippman S.M. et al. Clin. Cancer Res. 17:7003-7014(2011) · Mapped (27) |
| Stella-Cre mice are highly efficient Cre deleters. Liu H., Wang W., Chew S.K., Lee S.C., Li J., Vassiliou G.S., Green T., Futreal P.A., Bradley A., Zhang S. et al. Genesis 49:689-695(2011) · Mapped (11) |
| DICER1 syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome. Slade I., Bacchelli C., Davies H., Murray A., Abbaszadeh F., Hanks S., Barfoot R., Burke A., Chisholm J., Hewitt M. et al. J. Med. Genet. 48:273-278(2011) · Mapped (6) |
| Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Varela I., Tarpey P., Raine K., Huang D., Ong C.K., Stephens P., Davies H., Jones D., Lin M.L., Teague J. et al. Nature 469:539-542(2011) · UniProtKB (74) |
| Genetic and structural variation in the gastric cancer kinome revealed through targeted deep sequencing. Zang Z.J., Ong C.K., Cutcutache I., Yu W., Zhang S.L., Huang D., Ler L.D., Dykema K., Gan A., Tao J. et al. Cancer Res. 71:29-39(2011) · UniProtKB (2) |
| GLO1-A novel amplified gene in human cancer. Santarius T., Bignell G.R., Greenman C.D., Widaa S., Chen L., Mahoney C.L., Butler A., Edkins S., Waris S., Thornalley P.J. et al. Genes Chromosomes Cancer 49:711-725(2010) · Mapped (1) |
| Mutations in the guanine nucleotide exchange factor gene IQSEC2 cause nonsyndromic intellectual disability. Shoubridge C., Tarpey P.S., Abidi F., Ramsden S.L., Rujirabanjerd S., Murphy J.A., Boyle J., Shaw M., Gardner A., Proos A. et al. |
| Interleukin-8 mediates resistance to antiangiogenic agent sunitinib in renal cell carcinoma. Huang D., Ding Y., Zhou M., Rini B.I., Petillo D., Qian C.N., Kahnoski R., Futreal P.A., Furge K.A., Teh B.T. Cancer Res. 70:1063-1071(2010) · Mapped (1) |
| Novel candidate cancer genes identified by a large-scale cross-species comparative oncogenomics approach. Mattison J., Kool J., Uren A.G., de Ridder J., Wessels L., Jonkers J., Bignell G.R., Butler A., Rust A.G., Brosch M. et al. Cancer Res. 70:883-895(2010) · Mapped (50) |
| Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Dalgliesh G.L., Furge K., Greenman C., Chen L., Bignell G., Butler A., Davies H., Edkins S., Hardy C., Latimer C. et al. Nature 463:360-363(2010) · Mapped (20) |
| Identification and characterization of two novel JARID1C mutations: suggestion of an emerging genotype-phenotype correlation. Rujirabanjerd S., Nelson J., Tarpey P.S., Hackett A., Edkins S., Raymond F.L., Schwartz C.E., Turner G., Iwase S., Shi Y. et al. Eur. J. Hum. Genet. 18:330-335(2010) · Mapped (3) |
| A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation. Tarpey P.S., Smith R., Pleasance E., Whibley A., Edkins S., Hardy C., O'Meara S., Latimer C., Dicks E., Menzies A. et al. |
| Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. van Haaften G., Dalgliesh G.L., Davies H., Chen L., Bignell G., Greenman C., Edkins S., Hardy C., O'Meara S., Teague J. et al. Nat. Genet. 41:521-523(2009) · Mapped (17) |
| LKB1/KRAS mutant lung cancers constitute a genetic subset of NSCLC with increased sensitivity to MAPK and mTOR signalling inhibition. Mahoney C.L., Choudhury B., Davies H., Edkins S., Greenman C., Haaften G., Mironenko T., Santarius T., Stevens C., Stratton M.R. et al. Br. J. Cancer 100:370-375(2009) · Mapped (6) |
| X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment. Dibbens L.M., Tarpey P.S., Hynes K., Bayly M.A., Scheffer I.E., Smith R., Bomar J., Sutton E., Vandeleur L., Shoubridge C. et al. |
| Oligosaccharyltransferase-subunit mutations in nonsyndromic mental retardation. Molinari F., Foulquier F., Tarpey P.S., Morelle W., Boissel S., Teague J., Edkins S., Futreal P.A., Stratton M.R., Turner G. et al. Am. J. Hum. Genet. 82:1150-1157(2008) · UniProtKB (2) · Mapped (9) |
| Feedback circuit among INK4 tumor suppressors constrains human glioblastoma development. Wiedemeyer R., Brennan C., Heffernan T.P., Xiao Y., Mahoney J., Protopopov A., Zheng H., Bignell G., Furnari F., Cavenee W.K. et al. Cancer Cell 13:355-364(2008) · Mapped (3) |
| SLC9A6 mutations cause X-linked mental retardation, microcephaly, epilepsy, and ataxia, a phenotype mimicking Angelman syndrome. Gilfillan G.D., Selmer K.K., Roxrud I., Smith R., Kyllerman M., Eiklid K., Kroken M., Mattingsdal M., Egeland T., Stenmark H. et al. Am. J. Hum. Genet. 82:1003-1010(2008) · UniProtKB (1) · Mapped (3) |
| Submicroscopic duplications of the hydroxysteroid dehydrogenase HSD17B10 and the E3 ubiquitin ligase HUWE1 are associated with mental retardation. Froyen G., Corbett M., Vandewalle J., Jarvela I., Lawrence O., Meldrum C., Bauters M., Govaerts K., Vandeleur L., Van Esch H. et al. Am. J. Hum. Genet. 82:432-443(2008) · UniProtKB (2) · Mapped (11) |
| Mutations in UPF3B, a member of the nonsense-mediated mRNA decay complex, cause syndromic and nonsyndromic mental retardation. Tarpey P.S., Raymond F.L., Nguyen L.S., Rodriguez J., Hackett A., Vandeleur L., Smith R., Shoubridge C., Edkins S., Stevens C. et al. |